Importance of management of elevated intracranial pressure associated with cryptococcal meningitis in patients with acquired immunodeficiency syndrome. A report of two cases;Importancia del manejo de la hipertensión endocraneana en meningitis criptocócica en pacientes con síndrome de inmunodeficiencia adquirida. Informe de dos casos

Revista de Investigacion Clinica

Volumn 51, Issue 5, 1999, Pages 303-307

  Niño Oberto, Sandra ^a,b   Estañol Vidal, Bruno ^a   García Ramos, Guillermo ^a   Vega Boada, Felipe ^a   Sierra Madero, Juan ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INNSZ ^*  (Mexico)

Author keywords

Cryptococcal meningitis; Elevated intracranial pressure; Lumboperitoneal shunt

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CRYPTOCOCCAL MENINGITIS; HUMAN; INTRACRANIAL HYPERTENSION; MALE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MENINGITIS, CRYPTOCOCCAL;

EID: 0033181955     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Van der Horst CM, Saag M, Cloud G. Treatment of cryptococcal meningitis associated with acquired immunodeficiency syndrome. N Engl J Med 1997; 337: 15-21.
2. Chuck S, Sande M. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 794-99.
3. Powderly. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993; 17: 837-42.
4. Denning D, Armstrong R. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991; 91: 267-72.
5. Larsen R, Bozzette S, Jones B. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994; 741-5.
6. Dimond RD. Effects of stimulation and suppression of cell-mediated immunity on cryptococcus. Infect Human 1977; 60: 3122-7.
7. Chung K, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Human 1986; 51: 218-23.
8. Bennett JE, Dismuskes WE. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301: 126-31.
9. Tan CT. Intracranial hypertension causing visual failure in cryptococcus meningitis. J Neurol Neurosurg Psychiatry 1988; 51: 944-6.
10. Francis P, Walsh TJ. Evolving role of flucytosine in immunocompromised patients: New sights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis 1992; 15: 1003-8.
11. Powderly WG. Therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1992; 14 (suppl 1): S54-9.
12. Bach MC, Tally Philip W, Godofsky EW. Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurgery 1997; 41: 1280-2.
13. Chan KH, Mann KS, Yue C. Neurosurgical aspects of cerebral cryptococcosis. Neurosurgery 1989;25:44-8.